Stockscreener 앱 받기
3.02
0.33%
0.01
시간 외 거래:
29.72
26.70
+884.11%
Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스
Relmada Therapeutics initiates Phase 1 dosing with REL-P11 - TipRanks
Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease - The Manila Times
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Relmada Therapeutics reports Q3 financials, focuses on REL-1017 - Investing.com Nigeria
Relmada Therapeutics hopes to hit big milestones by year-end - Green Market Report
Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights - GuruFocus.com
Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance UK
Relmada Therapeutics Inc. Reports Q3 2024 Financial Results - TipRanks
Relmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 - Quantisnow
Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - PR Newswire
Relmada Therapeutics (RLMD) Set to Announce Earnings on Thursday - MarketBeat
3 US Penny Stocks To Monitor In October 2024 - Simply Wall St
Q3 Earnings Estimate for RLMD Issued By Leerink Partnrs - MarketBeat
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Shares Purchased by Renaissance Technologies LLC - Defense World
Relmada Therapeutics (NASDAQ:RLMD) Shares Down 0.3%Should You Sell? - MarketBeat
Roblox Corp general counsel sells $774,810 in stock By Investing.com - Investing.com Canada
Roblox Corporation [RBLX] moved down -1.09: Why It’s Important - The DBT News
RBLX (Roblox Corporation) may reap gains as insiders became active recently - Knox Daily
Hancock Whitney Corp Reduces Stake in Relx Plc (NYSE:RELX) - Defense World
Bet on a Slow March Higher in Roblox (NYSE:RBLX) Stock with a Credit Spread - Nasdaq
RELX rises Monday, outperforms market - MarketWatch
Relx Plc (NYSE:RELX) Shares Bought by Mercer Global Advisors Inc. ADV - Defense World
Financial Health Report: Relmada Therapeutics Inc (RLMD)’s Ratios Tell a Tale - The Dwinnex
What's Going On With Richtech Robotics Stock? - Benzinga
Relx (NYSE:RELX) Hits New 12-Month High at $48.32 - MarketBeat
A new trading data show Relmada Therapeutics Inc (RLMD) is showing positive returns. - SETE News
Relmada Therapeutics (NASDAQ:RLMD) Stock Rating Upgraded by Jefferies Financial Group - Defense World
Understanding the Risks of Investing in Relmada Therapeutics Inc (RLMD) - Knox Daily
Why ResMed Stock Tumbled by 5% Today - The Motley Fool
Monitoring Collegium Pharmaceutical Inc (COLL) after recent insider movements - Knox Daily
Is Marvell Technology, Inc. (MRVL) The Worst 5G Stock to Buy According to Short Sellers? - Yahoo Finance
Relmada Therapeutics (NASDAQ:RLMD) Raised to Buy at Jefferies Financial Group - MarketBeat
Relmada Therapeutics Inc Inc. (RLMD) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Relmada stock jumps as Jefferies upgrades (NASDAQ:RLMD) - Seeking Alpha
Relmada stock's "risk/reward setup" could lead to big upsideJefferies - Investing.com
Finansavisen - Finansavisen
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm - PR Newswire
Relmada Therapeutics Inc (RLMD) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Insider Spends US$395k Buying More Shares In Relmada Therapeutics - Yahoo Finance
Relmada Therapeutics CFO buys $149,700 in company stock - Investing.com India
Analyst sustains stock target, outperform on Relmada amid insider buys - Investing.com India
Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc (RLMD) - Yahoo Finance
Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Th - GuruFocus.com
Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc (RLMD) By GuruFocus - Investing.com Canada
Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140 - GuruFocus.com
Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares By GuruFocus - Investing.com Canada
Relmada Therapeutics director buys $33,280 in company stock - Investing.com India
Relmada therapeutics CEO acquires shares worth over $395k - Investing.com India
Relmada Therapeutics director buys $33,280 in company stock By Investing.com - Investing.com Canada
Insider Buying: Relmada Therapeutics, Inc. (NASDAQ:RLMD) CFO Buys 8,194 Shares of Stock - MarketBeat
Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares - Yahoo Finance
Relmada Therapeutics (NASDAQ:RLMD) Trading Up 16.3% - MarketBeat
Relmada Therapeutics (NASDAQ:RLMD) Trading 16.3% Higher - Defense World
Insiders Who Purchased US$663.4k Of Relmada Therapeutics Stock May Not Have Expected 14% Tumble - Simply Wall St
Ratios Uncovered: Breaking Down Relmada Therapeutics Inc (RLMD)’s Trailing Twelve Months Metrics - The Dwinnex
Will Relmada Therapeutics (NASDAQ:RLMD) Spend Its Cash Wisely? - Yahoo Finance
Relmada Therapeutics to Participate in the Goldman Sachs 45th An - GuruFocus.com
3.66%
1.11%
자본화:
|
볼륨(24시간):